alb5536761

The Johnson & Johnson COVID-19 vaccine.

The Johnson & Johnson COVID-19 vaccine. Developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals. It is a viral vector vaccine based on a human adenovirus that has been modified to contain the gene for making the spike protein of the SARS-CoV-2 virus that causes COVID-19. The body's immune system responds to this spike protein to produce antibodies. The vaccine requires only one dose and does not need to be stored frozen. April 2021.
Compartir
pinterestPinterest
twitterTwitter
facebookFacebook
emailEmail

Añadir a otro lightbox

Añadir a otro lightbox

add to lightbox print share
¿Ya tienes cuenta? Iniciar sesión
¿No tienes cuenta? Regístrate
Compra esta imagen
Cargando...
Título:
The Johnson & Johnson COVID-19 vaccine.
The Johnson & Johnson COVID-19 vaccine. Developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals. It is a viral vector vaccine based on a human adenovirus that has been modified to contain the gene for making the spike protein of the SARS-CoV-2 virus that causes COVID-19. The body's immune system responds to this spike protein to produce antibodies. The vaccine requires only one dose and does not need to be stored frozen. April 2021.
Crédito:
Album / Universal History Archive/Universal Images Group
Autorizaciones:
Modelo: No - Propiedad: No
¿Preguntas relacionadas con los derechos?
Tamaño imagen:
5863 x 3577 px | 60.0 MB
Tamaño impresión:
49.6 x 30.3 cm | 19.5 x 11.9 in (300 dpi)
Palabras clave: